Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that …
Biotechnology
US, Palo Alto [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Kodiak Sciences Inc. (KOD) to it's peer group.
Peer Group
MDGL AKRO SRPT MRTX CTMX CKPT CGTX MBIO GOSS SPRO FIXX NLTX ICPT TIL RVPH RNAZ EYEN ASMB BMEA STOK
Compare Together
Loading...